ea0099p48 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024
Carreira Ana
, Lopes Sofia
, Hundarova Kristina
, Lobo Antonio
, Ceu Almeida Maria
, Ruas Luisa
, Paiva Sandra
, Melo Miguel
, Paiva Isabel
Introduction: Screening for gestational diabetes (GD) in the first trimester using fasting plasma glucose (FPG) ≥92 mg/dl is routinely performed in several countries. However, evidence on the benefits and harms of early universal screening, as well as the optimal cut-off of FPG, is conflicting. This results in lack of standardised screening and treatment approaches for GD worldwide.Aims: o compare the use of pharmacological treatment and pregnancy ...